ENADE Ciências Contábeis Practice Questions - ENADE Ciências Contábeis - Exame Nacional De Desempenho Dos Estudantes Exam

Access More Questions

A Brazilian pharmaceutical company spent R$ 5,000,000 during the fiscal year on scientific research activities aimed at discovering new chemical compounds, before proving technical and commercial feasibility. According to CPC 00 (R2) and CPC 04 (R1) Intangible Assets (Ativo Intangível), how should this expenditure be recognized in the financial statements?

Capitalized as an intangible asset under development and subjected to mandatory annual impairment testing. Recognized immediately as an operational expense in profit or loss (DRE) for the period in which it is incurred. Recorded in shareholders' equity under capital reserves until commercial authorization is granted by ANVISA. Deferred as a non-current prepaid expenditure and amortized linearly over the legal duration of the patents that the research is expected to generate.

Correct Answer:

Recognized immediately as an operational expense in profit or loss (DRE) for the period in which it is incurred.

Access more questions from this quiz

Continue to ENADE Ciências Contábeis Practice Questions - ENADE Ciências Contábeis - Exame Nacional de Desempenho dos Estudantes Exam for more practice questions and the full quiz experience.

Access More Questions